559
Views
20
CrossRef citations to date
0
Altmetric
Research Article

Applications of excipients in the field of 3D printed pharmaceuticals

, , , , , , , & show all
Pages 905-913 | Received 08 Aug 2018, Accepted 28 Jan 2019, Published online: 20 Mar 2019

References

  • Kim N, He N, Kim C, et al. Systematic analysis of genotype-specific drug responses in cancer. Int J Cancer. 2012;131:2456–2464.
  • Tian P, Yang F, Xu Y, et al. Oral disintegrating patient-tailored tablets of warfarin sodium produced by 3D printing. Drug Dev Ind Pharm. 2018;44:1918–1923.
  • Zhang J, Vo AQ, Feng X, et al. Pharmaceutical additive manufacturing: a novel tool for complex and personalized drug delivery systems. AAPS PharmSciTech. 2018; 19: 3388–3402.
  • Fina F, Goyanes A, Gaisford S, et al. Selective laser sintering (SLS) 3D printing of medicines. Int J Pharm. 2017;529:285–293.
  • Goyanes A, Fina F, Martorana A, et al. Development of modified release 3D printed tablets (printlets) with pharmaceutical excipients using additive manufacturing. Int J Pharm. 2017;527:21–30.
  • Goyanes A, Martinez PR, Buanz A, et al. Effect of geometry on drug release from 3D printed tablets. Int J Pharm. 2015;494:657–663.
  • Melocchi A, Parietti F, Maccagnan S, et al. Industrial development of a 3D-printed nutraceutical delivery platform in the form of a multicompartment HPC capsule. AAPS PharmSciTech. 2018;19:3343–3354.
  • Okwuosa TC, Soares C, Gollwitzer V, et al. On demand manufacturing of patient-specific liquid capsules via co-ordinated 3D printing and liquid dispensing. Eur J Pharm Sci. 2018;118:134–143.
  • Tagami T, Fukushige K, Ogawa E, et al. 3D printing factors important for the fabrication of polyvinylalcohol filament-based tablets. Biol Pharm Bull. 2017;40:357–364.
  • Trenfield SJ, Awad A, Goyanes A, et al. 3D printing pharmaceuticals: drug development to frontline care. Trends Pharmacol Sci. 2018;39:440–451.
  • Awad A, Trenfield SJ, Goyanes A, et al. Reshaping drug development using 3D printing. Drug Discov Today. 2018;23: 1547–1555.
  • Beck RCR, Chaves PS, Goyanes A, et al. 3D printed tablets loaded with polymeric nanocapsules: an innovative approach to produce customized drug delivery systems. Int J Pharm. 2017;528:268–279.
  • Goyanes A, Kobayashi M, Martínez-Pacheco R, et al. Fused-filament 3D printing of drug products: microstructure analysis and drug release characteristics of PVA-based caplets. Int J Pharm. 2016;514:290–295.
  • Maroni A, Melocchi A, Parietti F, et al. 3D printed multi-compartment capsular devices for two-pulse oral drug delivery. J Control Release. 2017;268:10–18.
  • Martinez PR, Goyanes A, Basit AW, et al. Influence of geometry on the drug release profiles of stereolithographic (SLA) 3D-printed tablets. AAPS PharmSciTech. 2018;19: 3355–3361.
  • Sadia M, Arafat B, Ahmed W, et al. Channelled tablets: an innovative approach to accelerating drug release from 3D printed tablets. J Control Release. 2018;269:355–363.
  • Arafat B, Wojsz M, Isreb A, et al. Tablet fragmentation without a disintegrant: a novel design approach for accelerating disintegration and drug release from 3D printed cellulosic tablets. Eur J Pharm Sci. 2018;118:191–199.
  • Fina F, Madla CM, Goyanes A, et al. Fabricating 3D printed orally disintegrating printlets using selective laser sintering. Int J Pharm. 2018;541:101–107.
  • Awad A, Trenfield SJ, Gaisford S, et al. 3D printed medicines: a new branch of digital healthcare. Int J Pharm. 2018;548: 586–596.
  • Kollamaram G, Croker DM, Walker GM, et al. Low temperature fused deposition modeling (FDM) 3D printing of thermolabile drugs. Int J Pharm. 2018;545:144–152.
  • Goyanes A, Fernández-Ferreiro A, Majeed A, et al. PET/CT imaging of 3D printed devices in the gastrointestinal tract of rodents. Int J Pharm. 2018;536:158–164.
  • Lim SH, Kathuria H, Tan JJY, et al. 3D printed drug delivery and testing systems - a passing fad or the future? Adv Drug Deliv Rev. 2018;132:139–168.
  • Nasereddin JM, Wellner N, Alhijjaj M, et al. Development of a simple mechanical screening method for predicting the feedability of a pharmaceutical FDM 3D printing filament. Pharm Res. 2018;35:151.
  • Smith DM, Kapoor Y, Klinzing GR, et al. Pharmaceutical 3D printing: design and qualification of a single step print and fill capsule. Int J Pharm. 2018;544:21–30.
  • Trenfield SJ, Goyanes A, Telford R, et al. 3D printed drug products: non-destructive dose verification using a rapid point-and-shoot approach. Int J Pharm. 2018;549:283–292.
  • Goyanes A, Scarpa M, Kamlow M, et al. Patient acceptability of 3D printed medicines. Int J Pharm. 2018;530:71–78.
  • Liang K, Carmone S, Brambilla D, et al. 3D printing of a wearable personalized oral delivery device: a first-in-human study. Sci Adv. 2018;4:eaat2544.
  • Palekar S, Nukala PK, Mishra SM, et al. Application of 3D printing technology and quality by design approach for development of age-appropriate pediatric formulation of baclofen. Int J Pharm. 2018;556: 106–116.
  • Sun Y, Soh S. Printing tablets with fully customizable release profiles for personalized medicine. Adv Mater Weinheim. 2015;27:7847–7853.
  • Tagami T, Nagata N, Hayashi N, et al. Defined drug release from 3D-printed composite tablets consisting of drug-loaded polyvinylalcohol and a water-soluble or water-insoluble polymer filler. Int J Pharm. 2018;543:361–367.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.